Previous studies have indicated that the anti-RNP antibody in PAH might be implicated in injuring pulmonary vascular endothelial cells, inducing the proliferation of smooth muscle fibers [33, 34]. Here, RNPC3 is linked to pulmonary arterial hypertension.